Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma

C Boutin1, M Schlesser, C Frenay

  • 1Dept of Pulmonary Diseases, Hôpital de La Conception, Marseille, France.

The European Respiratory Journal
|November 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study.

Respiratory research·2020
Same author

Statistical analysis of the effluent quality of 231 on-site sanitation facilities in France monitored during a 6-year period.

Water science and technology : a journal of the International Association on Water Pollution Research·2019
Same author

[Management of a tracheal adenoid cystic medico-surgical carcinoma].

Revue des maladies respiratoires·2018
Same author

[Trans-vocal cord prostheses - preliminary experience treating benign laryngotracheal stenosis in adults].

Revue des maladies respiratoires·2018
Same author

Macrophytes are highly sensitive to the herbicide diquat dibromide in test systems of varying complexity.

Ecotoxicology and environmental safety·2018
Same author

[Blue rubber bleb naevus syndrome involving the pleura].

Revue des maladies respiratoires·2018
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same journal

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same journal

Clinical Practice Guideline for the diagnosis of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency Disorders (CVID) - an ERS Clinical Research Collaboration.

The European respiratory journal·2026
Same journal

Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapies.

The European respiratory journal·2026
Same journal

Progressive pulmonary fibrosis: a state-of-the-art review.

The European respiratory journal·2026
Same journal

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026
See all related articles

Malignant pleural mesothelioma (MPM) has a poor prognosis, but early diagnosis and multimodal therapy may improve outcomes. Further research is needed to establish optimal treatment strategies for MPM.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pulmonology

Background:

  • Malignant pleural mesothelioma (MPM) incidence has increased, with a poor prognosis and limited effective treatments.
  • Current survival rates are approximately 12-17 months post-diagnosis.
  • Early screening for MPM has received limited attention due to its generally poor prognosis.

Purpose of the Study:

  • To review current understanding of malignant pleural mesothelioma diagnosis and treatment.
  • To discuss potential benefits of early diagnosis and multimodal therapy.
  • To outline proposed treatment strategies based on disease stage.

Main Methods:

  • Histological analysis of thoracoscopy samples for diagnosis and staging.
  • Assessment of visceral pleural involvement as a prognostic factor.

Related Experiment Videos

  • Review of existing treatment modalities including radiotherapy, surgery, chemotherapy, and immunotherapy.

    • Main Results:

    • Thoracoscopy is crucial for accurate staging and identifying prognostic factors.
    • No single treatment has demonstrated definitive superiority in randomized trials.
    • Early-stage MPM may benefit from neoadjuvant intrapleural cytokine therapy.
    • Advanced stages may require multimodal treatment including surgery, radiotherapy, and chemotherapy.

    Conclusions:

    • Early diagnosis and multimodal therapy, including intrapleural immunotherapy, may offer improved prognosis for certain MPM cases.
    • Treatment strategies should be tailored to disease stage, with consideration for neoadjuvant therapy in early stages and multimodal approaches in advanced stages.
    • Enrollment in clinical trials is recommended for all MPM patients to advance treatment research.